Spring direct naar de hoofdnavigatie of de inhoud
‘Patents can work for or against you. Creating your own patent portfolio, while mitigating the risks of your competitors’ IP rights, is essential for success in today’s technology-based economy.’
Tamara Elmore

Tamara Elmore

  • Life Sciences
  • European and Dutch Patent Attorney, European Patent Litigator
  • United States Patent Agent
  • Partner

Tamara Elmore is a Dutch and European patent attorney and a United States patent agent. She started her career at a large pharmaceutical company in Switzerland, before joining an IP office in Boston as a US patent agent. In 2009, she switched to V.O. where she is active as a patent attorney in the Chemistry & Life Sciences Department.

Continue reading

One of her goals is to provide clients with the information and analysis that will enable them to make informed business decisions over complex intellectual property matters.

Tamara’s focus is on obtaining patent protection for her clients’ inventions and strategically managing their patent portfolios. Additional aspects of her practice include patent validity and infringement analysis as well as IP due diligence.

In her capacity as European Patent Litigator, Tamara is allowed to act as UPC representative.

Working experience

  • Patent Attorney, V.O. (2009-present)
  • United States Patent Agent, Ropes & Gray (2006-2009)
  • European Patent Attorney trainee, Hoffman La-Roche (2005)
  • Post-doc, University of Zurich (2002 – 2004)

Education

  • Master in Intellectual Property, ETH, Zurich (2005)
  • PhD in Molecular Biology, University of Texas Southwestern (2002)
  • MSc in Zoology, Texas Tech University (1995)

Directories

  • Recognized as IP Star (2024, 2025) and ranked among the ‘Top 250 Women in IP’ (2023) by Managing Intellectual Property

Publications

  • Elmore T, Reach-through royalty provisions in licensing contracts; The Berkeley Electronic Press (bepress) 2005 http://www.bepress.com/ndsip/reports/art2
  • Elmore T, Ignell R, Carlson JR, Smith DP. Targeted mutation of a Drosophila odor receptor defines receptor requirement in a novel class of sensillum. J Neurosci. 2003 Oct 29;23(30):9906-12.
  • Elmore T, Smith DP. Putative Drosophila odor receptor OR43b localizes to dendrites of olfactory neurons. Insect Biochem Mol Biol. 2001 Jun 22;31(8):791-8.
  • Elmore T, Rodriguez A, Smith DP. dRGS7 encodes a Drosophila homolog of EGL-10 and vertebrate RGS7. DNA Cell Biol. 1998 Nov;17(11):983-9.

Languages

  • English

Also see these experts

Blijke Kroezen

Blijke Kroezen

  • European and Dutch Patent Attorney, European Patent Litigator
  • Senior Associate
More experts

News

Trade secrets: the importance of discretion

Annelies de Bosch Kemper-de Hilster, Head of Legal at V.O., explains why trade secrets play an important role within organizations.Continue reading

T 873/24 and the reach of G 1/24 claim interpretation in added-matter analysis (Board of Appeal 3.3.05) 

In T 873/24 (Board of Appeal 3.3.05, oral proceedings 3 February 2026), the Board indicated that it would refer questions to the Enlarged Board of Appeal (EBA) on whether (and how) the Enlarged Board’s claim-interpretation guidance in G 1/24 extends to the assessment of added subject-matter under Article 123(2) EPC (and, by implication, Article 76(1) […]Continue reading

Düsseldorf Local Division adopts The Hague’s four-step test for infringement by equivalence and applies a structured “feature-by-feature function” analysis 

In its decision in Wonderland v Cybex (UPC_CFI_807/2024 and UPC_CFI_334/2025, Local Division Düsseldorf, 27 May 2026), the Düsseldorf panel addressed — in detail — the assessment of patent infringement by equivalent means under Art. 69 EPC and the Protocol.Continue reading

Events

BIO International Convention 2026

San Diego Convention Center, Harbor Drive, San Diego, San Diego, CA, USA

BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe.

Continue reading